Latest & greatest articles for pregnancy

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pregnancy or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pregnancy and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pregnancy

121. Guidance on self-monitoring of blood pressure in pregnancy

Guidance on self-monitoring of blood pressure in pregnancy 1 Information for healthcare professionals Version 1: Published Monday 30 March 2020 Self-monitoring of blood pressure in pregnancy2 1. Introduction The COVID-19 pandemic has required the NHS to urgently consider blood pressure (BP) self-monitoring in order to reduce face to face consultations for pregnant and postnatal women, whilst maintaining adequate safety for the woman and her baby. BP self-monitoring in pregnancy can either (...) with chronic hypertension, based on their care outside of pregnancy. 1.1 Scope This guidance covers pregnant women who currently require blood pressure monitoring (at varying frequencies) throughout the antenatal and postnatal period, during the period of COVID-19 pandemic. For women with chronic hypertension, gestational hypertension or pre-eclampsia, more frequent BP monitoring is required, over and above standard antenatal care. Other groups of women may also require increased frequency if they have

2020 Royal College of Obstetricians and Gynaecologists

122. Management of pregnant women with known or suspected COVID-19

Management of pregnant women with known or suspected COVID-19 Obstetric anaesthesia — ICM Anaesthesia COVID-19 Open Menu Close Menu The above guidance was commissioned from the Obstetric Anaesthetists’ Association (OAA) by the Faculty of Intensive Care Medicine, the Intensive Care Society, the Association of Anaesthetists and the Royal College of Anaesthetists. It reflects the expert opinion of senior clinicians and is based in part on published information from the current and previous (...) coronavirus outbreaks. It is correct at the time of publication but please be aware that it is subject to change as new information becomes available. We would from people as they gain experience of managing these patients. Our intention is to provide principles upon which to base the management of pregnant women with known or suspected COVID-19, but each unit will need to prepare their own detailed guidance appropriate to their setting. They will also need to liaise with services including

2020 ICM Anaesthesia COVID-19

123. Outcome of Coronavirus spectrum infections (SARS, MERS, COVID 1 -19) during pregnancy: a systematic review and meta-analysis

Outcome of Coronavirus spectrum infections (SARS, MERS, COVID 1 -19) during pregnancy: a systematic review and meta-analysis Redirecting

2020 Covid-19 Ad hoc papers

124. Coronavirus (COVID-19) Infection in Pregnancy

Coronavirus (COVID-19) Infection in Pregnancy 1 Information for healthcare professionals Version 1: Published Monday 9 March, 2020 Coronavirus (COVID-19) Infection in Pregnancy2 Table of contents Introduction 3-5 Advice for health professionals to share with pregnant women 7-9 Advice for services caring for women with suspected or confirmed COVID-19 11-23 Advice for services caring for women following recovery from confirmed COVID-19 25 Acknowledgements 26 Flow chart to assess COVID-19 risk (...) should not be altered based on pregnancy status. In the UK, pregnant women should be investigated and diagnosed as per local / Public Health England 8 /Health Protection Scotland 9 criteria. Obstetricians and midwives should liaise with their local virology service / health protection team for further details about arrangements for testing and notification reporting of a positive test result. hospital is advised, pregnant women are requested to travel by private transport and alert the maternity

2020 Royal College of Obstetricians and Gynaecologists

125. Antiepileptics and pregnancy: potential long-term effects in children

and pregnancy: potential long-term effects in children FEATURED REVIEW Many women who could become pregnant are exposed to antiepileptic drugs. Yet most of the antiepileptic drugs taken by pregnant women expose the unborn child to the risk of malformations, fetotoxic effects and neonatal disorders. What are the long-term effects of the most widely used antieleptics on children exposed in utero, and how do they compare? Full review (8 pages) available for download by subscribers. Abstract What are the main (...) Antiepileptics and pregnancy: potential long-term effects in children Prescrire IN ENGLISH - Spotlight ''Antiepileptics and pregnancy: potential long-term effects in children'', 1 January 2020 {1} {1} {1} | | > > > Antiepileptics and pregnancy: potential long-term effects in children Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight Antiepileptics

2020 Prescrire

126. Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up. Full Text available with Trip Pro

Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up. To evaluate the associations between maternal diabetes diagnosed before or during pregnancy and early onset cardiovascular disease (CVD) in offspring during their first four decades of life.Population based cohort study.Danish national health registries.All 2 432 000 liveborn children without congenital heart disease in Denmark during 1977-2016

2019 BMJ

127. Pregnant Women Who Have Periodontal Disease Are at an Increased Risk for Pre-Term Birth and/or a Low Birth Weight Child

Pregnant Women Who Have Periodontal Disease Are at an Increased Risk for Pre-Term Birth and/or a Low Birth Weight Child UTCAT3410, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Pregnant Women Who Have Periodontal Disease Are at an Increased Risk for Pre-Term Birth and/or a Low Birth Weight Child Clinical Question Are pregnant women who have periodontal disease at a higher risk for having pre-term birth or low birth (...) weight children compared to pregnant women who do not have periodontal disease? Clinical Bottom Line Pregnant women who have periodontal disease are at an increased risk for having a pre-term birth (PB) and/or low birth weight (LBW) child. This association is supported by several systematic reviews looking at pregnant women with periodontal disease and the occurrence of PB and LWB. Educating women of childbearing years and preventing periodontal disease could help reduce the amount of women

2019 UTHSCSA Dental School CAT Library

128. Practice Advisory: Management of Pregnant and Reproductive-Aged Women during a Measles Outbreak

persons are at increased risk of severe illness and complications of measles 2 . The two-dose series of the measles-mumps-rubella (MMR) vaccine is safe and is 97% effective at preventing measles infection 2 . Measles Infection during Pregnancy Measles infection in pregnant women is associated with several adverse events including increased risk of hospitalization and pneumonia 3 . Measles infection during pregnancy is also associated with significant risks to the fetus 4-6 , including: Miscarriage (...) ; however, inadvertent MMR vaccination in the periconception period or in early pregnancy should not be considered an indication for termination of pregnancy 4 . Pregnancy One documented dose of MMR vaccine is sufficient for low risk individuals (including pregnant women). For people at high risk of contracting measles, a documented history of two prior MMR vaccine doses is needed to confirm immunity. However, obstetrician-gynecologists should consult their local health departments when determining

2019 American College of Obstetricians and Gynecologists

129. AmnioSense for unexplained vaginal wetness in pregnancy

AmnioSense for unexplained vaginal wetness in pregnancy AmnioSense for unexplained vaginal wetness in pregnancy Medtech innovation briefing Published: 26 November 2019 www.nice.org.uk/guidance/mib198 pathways Summary Summary The technology technology described in this briefing is AmnioSense. It is used for identifying leaking amniotic fluid in pregnant women with unexplained vaginal wetness. The inno innovativ vative aspects e aspects are that AmnioSense is a non-invasive test that uses a pH (...) testing and ultrasound examination of the uterus. However, these assessments are not routine practice in the NHS. P Population, setting and intended user opulation, setting and intended user AmnioSense is intended for pregnant women who have unexplained vaginal wetness. The technology is targeted towards women who are in their second or third trimester of pregnancy. The technology is designed to be used by primary and community care clinical staff or at home by pregnant women. Instructions for use

2019 National Institute for Health and Clinical Excellence - Advice

130. Continuous Glucose Monitoring in Pregnancy

Continuous Glucose Monitoring in Pregnancy Continuous Glucose Monitoring in Pregnancy - Health Technology Wales > Continuous Glucose Monitoring in Pregnancy Continuous Glucose Monitoring in Pregnancy Topic Status Incomplete Continuous glucose monitoring systems for managing diabetes in pregnant women. Summary Health Technology Wales researchers searched for evidence on the clinical and cost effectiveness of continuous glucose monitoring as an aid to managing diabetes for pregnant women. Based

2019 Health Technology Wales

131. Association Between Pregnancy Outcomes and Radioactive Iodine Treatment After Thyroidectomy Among Women With Thyroid Cancer Full Text available with Trip Pro

Association Between Pregnancy Outcomes and Radioactive Iodine Treatment After Thyroidectomy Among Women With Thyroid Cancer Current guidelines recommend that women delay pregnancy for 6 to 12 months after the receipt of radioactive iodine treatment (RAIT) following thyroidectomy for differentiated thyroid carcinoma. Although concerns exist regarding the risks associated with pregnancy after RAIT, no large-scale study, to date, has investigated the association between RAIT and pregnancy (...) outcomes.To investigate whether RAIT was associated with increases in adverse pregnancy outcomes among South Korean women who received RAIT after thyroidectomy for thyroid cancer and to evaluate the appropriate interval between RAIT and conception.This population-based cohort study used the Health Insurance Review and Assessment database of South Korea to identify a total of 111 459 women of childbearing age (20-49 years) who underwent thyroidectomy for the treatment of differentiated thyroid carcinoma

2019 EvidenceUpdates

132. Pregnancy and Maternal Obesity Part 2: Team Planning for Delivery and Postpartum Care

Pregnancy and Maternal Obesity Part 2: Team Planning for Delivery and Postpartum Care Pregnancy and Maternal Obesity Part 2: Team Planning for Delivery and Postpartum Care Toggle navigation Toggle search Keyword search language Keyword search Pregnancy and Maternal Obesity Part 2: Team Planning for Delivery and Postpartum Care If you are not automatically redirected to the JOGC site within 15 seconds, please click the link above. No information available ID Access The Society of Obstetricians

2019 Society of Obstetricians and Gynaecologists of Canada

133. Pregnancy and Maternal Obesity Part 1: Pre-conception and Prenatal Care

Pregnancy and Maternal Obesity Part 1: Pre-conception and Prenatal Care Pregnancy and Maternal Obesity Part 1: Pre-conception and Prenatal Care Toggle navigation Toggle search Keyword search language Keyword search Pregnancy and Maternal Obesity Part 1: Pre-conception and Prenatal Care If you are not automatically redirected to the JOGC site within 15 seconds, please click the link above. No information available ID Access The Society of Obstetricians and Gynaecologists of Canada (SOGC) {1} {1

2019 Society of Obstetricians and Gynaecologists of Canada

134. Effectiveness of routine third trimester ultrasonography to reduce adverse perinatal outcomes in low risk pregnancy (the IRIS study): nationwide, pragmatic, multicentre, stepped wedge cluster randomised trial. Full Text available with Trip Pro

Effectiveness of routine third trimester ultrasonography to reduce adverse perinatal outcomes in low risk pregnancy (the IRIS study): nationwide, pragmatic, multicentre, stepped wedge cluster randomised trial. To investigate the effectiveness of routine ultrasonography in the third trimester in reducing adverse perinatal outcomes in low risk pregnancies compared with usual care and the effect of this policy on maternal outcomes and obstetric interventions.Pragmatic, multicentre, stepped wedge (...) cluster randomised trial.60 midwifery practices in the Netherlands.13 046 women aged 16 years or older with a low risk singleton pregnancy.60 midwifery practices offered usual care (serial fundal height measurements with clinically indicated ultrasonography). After 3, 7, and 10 months, a third of the practices were randomised to the intervention strategy. As well as receiving usual care, women in the intervention strategy were offered two routine biometry scans at 28-30 and 34-36 weeks' gestation

2019 BMJ

135. Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women. (Abstract)

Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women. The safety, efficacy, and appropriate timing of isoniazid therapy to prevent tuberculosis in pregnant women with human immunodeficiency virus (HIV) infection who are receiving antiretroviral therapy are unknown.In this multicenter, double-blind, placebo-controlled, noninferiority trial, we randomly assigned pregnant women with HIV infection to receive isoniazid preventive therapy for 28 weeks, initiated either during (...) pregnancy (immediate group) or at week 12 after delivery (deferred group). Mothers and infants were followed through week 48 after delivery. The primary outcome was a composite of treatment-related maternal adverse events of grade 3 or higher or permanent discontinuation of the trial regimen because of toxic effects. The noninferiority margin was an upper boundary of the 95% confidence interval for the between-group difference in the rate of the primary outcome of less than 5 events per 100 person

2019 NEJM

136. Regimens of vitamin D supplementation for women during pregnancy. Full Text available with Trip Pro

Regimens of vitamin D supplementation for women during pregnancy. Vitamin D deficiency during pregnancy increases the risk of pre-eclampsia, gestational diabetes, preterm birth, and low birthweight. In a previous Cochrane Review we found that supplementing pregnant women with vitamin D alone compared to no vitamin D supplementation may reduce the risk of pre-eclampsia, gestational diabetes, and low birthweight and may increase the risk of preterm births if it is combined with calcium. However (...) the effects of different vitamin D regimens are not yet clear.To assess the effects and safety of different regimens of vitamin D supplementation alone or in combination with calcium or other vitamins, minerals or nutrients during pregnancy, specifically doses of 601 international units per day (IU/d) or more versus 600 IU/d or less; and 4000 IU/d or more versus 3999 IU/d or less.We searched the Cochrane Pregnancy and Childbirth's Trials Register, ClinicalTrials.gov, the WHO International Clinical Trials

2019 Cochrane

137. Buprenorphine for Opioid Use Disorders during Pregnancy: A Review of Comparative Clinical Effectiveness, Safety, Cost-Effectiveness, and Guidelines

in preference to the buprenorphine-naloxone formulation for opioid use disorders during pregnancy. One other Canadian guideline cited the same evidence to support the use of buprenorphine-naloxone as a safe and effective alternative to buprenorphine alone during pregnancy. No additional recommendations for various buprenorphine or buprenorphine-naloxone formulations during pregnancy were identified. Evidence-based treatment of pregnant patients with opioid use disorders requires further well-controlled (...) Buprenorphine for Opioid Use Disorders during Pregnancy: A Review of Comparative Clinical Effectiveness, Safety, Cost-Effectiveness, and Guidelines Buprenorphine for Opioid Use Disorders during Pregnancy: A Review of Comparative Clinical Effectiveness, Safety, Cost-Effectiveness, and Guidelines | CADTH.ca Find the information you need Buprenorphine for Opioid Use Disorders during Pregnancy: A Review of Comparative Clinical Effectiveness, Safety, Cost-Effectiveness, and Guidelines Buprenorphine

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

138. Pregnancy Testing for Patients Requiring Diagnostic Imaging or Surgery in the Emergency Department: Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Pregnancy Testing for Patients Requiring Diagnostic Imaging or Surgery in the Emergency Department: Clinical Effectiveness, Cost-Effectiveness, and Guidelines Pregnancy Testing for Patients Requiring Diagnostic Imaging or Surgery in the Emergency Department: Clinical Effectiveness, Cost-Effectiveness, and Guidelines | CADTH.ca Find the information you need Pregnancy Testing for Patients Requiring Diagnostic Imaging or Surgery in the Emergency Department: Clinical Effectiveness, Cost (...) -Effectiveness, and Guidelines Pregnancy Testing for Patients Requiring Diagnostic Imaging or Surgery in the Emergency Department: Clinical Effectiveness, Cost-Effectiveness, and Guidelines Last updated: May 28, 2019 Project Number: RB1345-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What is the clinical effectiveness of performing a pregnancy test prior to diagnostic imaging or surgery in the emergency department setting? What

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

139. Caesarean Delivery for Pregnancies in the First Stage of Labor: Clinical Effectiveness and Guidelines

Caesarean Delivery for Pregnancies in the First Stage of Labor: Clinical Effectiveness and Guidelines Caesarean Delivery for Pregnancies in the First Stage of Labor: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Caesarean Delivery for Pregnancies in the First Stage of Labor: Clinical Effectiveness and Guidelines Caesarean Delivery for Pregnancies in the First Stage of Labor: Clinical Effectiveness and Guidelines Last updated: September 9, 2019 Project Number (...) : RB1393-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What are the benefits and harms of caesarean delivery for Robson group 1 pregnancies with failure to progress in the latent phase of labor? What are the benefits and harms of caesarean delivery for Robson group 2A pregnancies with failure to progress in the latent phase of labor? What are the benefits and harms of caesarean delivery for Robson group 1 pregnancies with failure

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

140. Caesarean Delivery for Pregnancies in the Second Stage of Labor: Clinical Effectiveness and Guidelines

Caesarean Delivery for Pregnancies in the Second Stage of Labor: Clinical Effectiveness and Guidelines Caesarean Delivery for Pregnancies in the Second Stage of Labor: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Caesarean Delivery for Pregnancies in the Second Stage of Labor: Clinical Effectiveness and Guidelines Caesarean Delivery for Pregnancies in the Second Stage of Labor: Clinical Effectiveness and Guidelines Last updated: September 16, 2019 Project (...) Number: RB1394-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What are the benefits and harms of caesarean delivery for Robson group 1 pregnancies with failure to progress in the second stage of labour? What are the benefits and harms of caesarean delivery for Robson group 2A pregnancies with failure to progress in the second stage of labour? What are the evidence-based guidelines regarding the use of caesarean delivery for Robson

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review